Skip to main content

BNP PARIBAS ARBITRAGE, SA

Position in URGN — UroGen Pharma Ltd.

CIK 1166588 NEW YORK, NY

Position in URGN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,604,443
+$1,433,274 QoQ
Shares Held
43,599
+358.0% QoQ
Ownership
0.089%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#65
of 190 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in URGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BNP PARIBAS ARBITRAGE, SA holds $3,331,911,027 across 414 Biotechnology names. URGN ranks #108 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in URGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,604,443 43,599
2026-03-31 $171,169 9,520
2025-12-31 $216,541 9,246
2025-09-30 $6,151,143 308,328
2025-06-30 $985,317 71,921
2025-03-31 $26,743 2,418
2024-12-31 $51,130 4,801
2024-09-30 $108,534 8,546
2024-06-30 $44,567 2,656
2024-03-31 $596,925 39,795
2023-12-31 $344,940 22,996
2023-09-30 $229,469 16,379
2023-06-30 $52,805 5,102
2023-03-31 $1,635 177
2022-12-31 $11,362 1,281
2022-09-30 $11,073 1,331
2022-06-30 $62,080 7,580
2022-03-31 $14,798 1,699
2021-12-31 $42,728 4,493
2021-09-30 $59,862 3,559
2021-06-30 $11,818 774
2021-03-31 $86,471 4,439
2020-12-31 $68,151 3,782
2020-09-30 $88,502 4,588
2020-06-30 $27,870 1,067
2020-03-31 $108,788 6,098